Leqembi's clinical benefit and safety will be evaluated by just a half dozen voting experts at a 9 June advisory committee meeting. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
